Search results for: 'mutant idh1 inhibitor'
-
B7932 NavoximodTarget: IDOSummary: Orally available inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1)
-
B5462 RotenoneTarget: complex I of the mitochondrial electron transport chainSummary: inhibitor of the mitochondrial complex I electron transport chain
-
B6304 Etazolate hydrochloride2 CitationTarget: Phosphodiesterases (PDEs)Summary: PDE-4 inhibitor and selective GABA-A receptor modulator
-
B5954 Dasatinib MonohydrateTarget: PDGFR|c-Kit|Bcr-Abl|SrcSummary: Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.
-
B7535 Eeyarestatin ITarget: ERADSummary: inhibitor of endoplasmic reticulum-associated degradation (ERAD) and protein translocation
-
B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase
-
B6831 Autocamtide-2-related inhibitory peptideTarget: Ca2 /calmodulin-dependent protein kinases (CaMKs)Summary: inhibitor of calmodulin-dependent protein kinase II (CaM-kinase II, CaMKII)
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
-
A4211 Lenalidomide (CC-5013)Target: angiogenesisSummary: Antineoplastic agent,inhibits angiogenesis
-
A4212 Pomalidomide (CC-4047)Summary: Immunomodulator,antumor/anti-angiogenic